{
    "paper_id": "6a980f71cc6c67df1c21281f2aa4acdcb4efd2aa",
    "metadata": {
        "title": "Supporting Information Anti-Dengue-Virus Activity and Structure-Activity Relationship Studies of Lycorine Derivatives",
        "authors": [
            {
                "first": "Peng",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Lin-Feng",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Qing-Yin",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Lu-Qing",
                "middle": [],
                "last": "Shang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Pei-Yong",
                "middle": [],
                "last": "Shi",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Zheng",
                "middle": [],
                "last": "Yin",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": ". The lycorine derivatives containing a modified A-ring, and their in vitro activities against DENV.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "a The molar concentration of a drug that causes 50% reduction in cell viability. b The molar concentration of a drug that inhibits 50% of viral antigen production. General procedure for 6-7",
            "cite_spans": [
                {
                    "start": 81,
                    "end": 82,
                    "text": "b",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "To a solution of 4 in 2 mL of methanol, anhydrous ketone (20 eq) and PTSA (0.2 eq) were added, and the mixture was refluxed at 70 \u00b0C for 20 h. The solvent was removed under reduced pressure followed by the addition of DCM and water. The organic layer was dried over anhydrous Na2SO4 and filtered. The filtrate was concentrated, and the crude residue was purified using silica gel chromatography to yield the product. 12-Methyl-12-propyllycorine (6)",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Following the previously described general procedure, 129 mg (0.47 mmol) of 4 yielded 6 as a pale solid (146 mg, 90.6%). 1 17.9, 24.0, 30.4, 42.7, 43.3, 54.5, 54.9, 62.0, 72.2, 75.0, 111.7, 113.4, 115.3, 122.2, 122.9, 129.9, 140.1, 145.8, 147.2 To a solution of 10 in anhydrous pyridine, acyl chloride or anhydride in anhydrous DCM was slowly added for 15 min at 0 \u00b0C. The solution was stirred at 0 \u00b0C until TLC analysis indicated that all of the starting material had been consumed. Subsequently, DCM and water were added. The organic layer was washed using an aqueous NaHCO3 solution and brine, dried over anhydrous Na2SO4 and filtered. The filtrate was concentrated under reduced pressure, and the crude residue was purified using silica gel chromatography to yield the products.",
            "cite_spans": [
                {
                    "start": 121,
                    "end": 122,
                    "text": "1",
                    "ref_id": null
                },
                {
                    "start": 123,
                    "end": 244,
                    "text": "17.9, 24.0, 30.4, 42.7, 43.3, 54.5, 54.9, 62.0, 72.2, 75.0, 111.7, 113.4, 115.3, 122.2, 122.9, 129.9, 140.1, 145.8, 147.2",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Following the previously described general procedure, 95 mg (0.28 mmol) of 10 yielded 12 as a pale solid (163 mg, 64.7%). 1 20.9, 22.2, 26.9, 28.7, 34.1, 40.4, 53.6, 56.7, 61.2, 69.2, 70.6, 101.0, 105.1, 107.3, 114.0, 126.6, 129.3, 145.8, 146.3, 146.5, 170.0, 172.5 , 1H) , 5.93 (s, 2H), 6.59 (s, 1H), 6.77 ppm (s, 1H); 13 C NMR (100 MHz, CDCl3): \u03b4=20.9, 27. 1, 28.6, 38.7, 40.6, 53.6, 56.8, 61.3, 69.1, 70.6, 101.0, 105.1, 107.3, 113.9, 126.6, 129.3, 145.8, 146.3, 146.5, 169.9, 177 ",
            "cite_spans": [
                {
                    "start": 122,
                    "end": 123,
                    "text": "1",
                    "ref_id": null
                },
                {
                    "start": 124,
                    "end": 265,
                    "text": "20.9, 22.2, 26.9, 28.7, 34.1, 40.4, 53.6, 56.7, 61.2, 69.2, 70.6, 101.0, 105.1, 107.3, 114.0, 126.6, 129.3, 145.8, 146.3, 146.5, 170.0, 172.5",
                    "ref_id": null
                },
                {
                    "start": 359,
                    "end": 483,
                    "text": "1, 28.6, 38.7, 40.6, 53.6, 56.8, 61.3, 69.1, 70.6, 101.0, 105.1, 107.3, 113.9, 126.6, 129.3, 145.8, 146.3, 146.5, 169.9, 177",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 266,
                    "end": 271,
                    "text": ", 1H)",
                    "ref_id": null
                }
            ],
            "section": "1-Acetyl-2-valeryllycorine (12)"
        },
        {
            "text": "Following the previously described general procedure, 120 mg ( 40.4, 45.1, 53.5, 56.6, 61.1, 68.9, 72.0, 72.0, 101.1, 104.9, 107.4, 113.3, 123.5, 126.2, 129.1, 130.9, 135.3, 146.5, 146.6, 147.0, 150.6, 163 28.7, 40.6, 53.6, 56.8, 61.3, 69.0, 71.3, 101.0, 105.1, 107.4, 113.7, 126.4, 128.3, 128.7, 129.3, 131.2, 139.6, 146.6, 164.4, 170.0 To a solution of 23 in 5 mL of anhydrous pyridine, chloride was added, and the solution was stirred at 0 \u00b0C until TLC analysis indicated that all of the starting material had been consumed followed by the addition of DCM and water. The organic layer was washed with an aqueous NaHCO3 solution and brine, dried over anhydrous Na2SO4 and filtered. The filtrate was concentrated under reduced pressure, and the crude residue was purified using silica gel chromatography to yield the products.\uf020 1-Butyryl-2-oxolycorine (35)",
            "cite_spans": [
                {
                    "start": 63,
                    "end": 205,
                    "text": "40.4, 45.1, 53.5, 56.6, 61.1, 68.9, 72.0, 72.0, 101.1, 104.9, 107.4, 113.3, 123.5, 126.2, 129.1, 130.9, 135.3, 146.5, 146.6, 147.0, 150.6, 163",
                    "ref_id": null
                },
                {
                    "start": 206,
                    "end": 337,
                    "text": "28.7, 40.6, 53.6, 56.8, 61.3, 69.0, 71.3, 101.0, 105.1, 107.4, 113.7, 126.4, 128.3, 128.7, 129.3, 131.2, 139.6, 146.6, 164.4, 170.0",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "1-Acetyl-2-(4-nitrobenzoyl)lycorine (18)"
        },
        {
            "text": "Following the previously described general procedure, 200 mg (0.70 mmol) of 23 yielded\uf02035 as a white solid (112 mg, 45.0%). 1 ",
            "cite_spans": [
                {
                    "start": 124,
                    "end": 125,
                    "text": "1",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "1-Acetyl-2-(4-nitrobenzoyl)lycorine (18)"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "58 (s, 1H), 6.73 ppm (s, 1H)",
            "authors": [],
            "year": null,
            "venue": "J=14.1 Hz, 1H), 5.92 (s, 2H), 6.05-5.97 (m, 2H)",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "mmol) of 23 yielded\uf02036 as a white solid (164 mg, 72.0%). 1 H NMR (400 MHz, CDCl3): \u03b4=0.76 (t, J=7.3 Hz, 3H), 1.13 (dd, J=12.0, 6.9 Hz, 2H), 1.51-1.38 (m, 2H)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "mmol) of 23 yielded 37 as a white solid (182 mg, 68.0%)",
            "authors": [],
            "year": null,
            "venue": "H NMR (400 MHz, CDCl3): \u03b4=0.79 (t, J=7.2 Hz, 3H)",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "92 (s, 2H), 6.00 (dd, J=6.4, 2.6 Hz, 2H), 6.57 (s, 1H), 6.73 ppm (s, 1H)",
            "authors": [],
            "year": null,
            "venue": "Hz, 1H), 3.27 (d, J=10.0 Hz, 1H), 3.47 (m, 1H), 3.60 (d, J=14.1 Hz, 1H), 4.17 (d, J=14.1 Hz, 1H)",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Following the previously described general procedure, 200 mg (0.70 mmol) of 23 yielded 40 as a white solid",
            "authors": [],
            "year": null,
            "venue": "mg, 48.0%). 1 H NMR (400 MHz, CDCl3): \u03b4=0.99 (s, 9H), 2.53 (q, J=8.6 Hz, 1H), 2.87 (s, 2H), 3.14 (d, J=9.8 Hz, 1H), 3.28 (d, J=9.7 Hz, 1H), 3.51-3.43 (m, 1H), 3.59 (d, J=14.1 Hz, 1H), 4.18 (d, J=14.1 Hz, 1H), 5.91 (d, J=2.6 Hz, 2H), 5.97 (d, J=2.6 Hz, 1H)",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "56 (s, 1H), 6.80 (s, 1H)",
            "authors": [],
            "year": null,
            "venue": "Hz, 1H), 5.88 (d, J=10.8 Hz, 2H), 6.06 (s, 1H), 6.23 (d, J=2.1 Hz, 1H)",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "-Methoxyl-benzoyl)-2-oxolycorine (41) Following the previously described general procedure, 200 mg (0.70 mmol) of 23 yielded 41 as a white solid (156 mg, 53.4%). 1 H NMR (400 MHz, CDCl3): \u03b4=2.59 (q, J=8.7 Hz, 1H), 2.90 (d, J=8.9 Hz, 2H)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "0.36 mmol) of 10 yielded 18 as a pale yellow solid (121 mg, 69.5%). 1 H NMR (400 MHz, CDCl3): \uf064\uf03d1.95 (s, 3H), 2.40 (m, 1H), 2.65 (m, 2H), 2.82 (d, J=10.0 Hz, 1H), 2.98 (d, J=10.4 Hz, 1H), 3.36 (m, 1H), 3.52 (d, J=14.0 Hz, 1H), 4.14 (d, J=14.4 Hz, 1H), 5.53 (s, 1H), 5.59 (s, 1H), 5.85 (s, 3H), 6.53 (s, 1H), 6.71 (s, 1H), 8.18 ppm (m, 4H); 13 C NMR (100 MHz, CDCl3): \uf064\uf03d28.8,",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Predicted pEC50 calculated by 3D-QSAR.",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "H NMR (400 MHz, CDCl3): \u03b4=0.91 (t, J=7.3 Hz, 3H), 1.36 (dd, J=15.0,",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "ppm; ESI-MS: m/z 414 [M+H] + ; HRMS: m/z [M+H] + calcd. forC23H28NO6: 414.1917C23H28NO6: 414. , found: 414.1905.",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "Hz, 1H), 4.22 (d, J=14.1 Hz, 1H), 5.55 (d, J=1.5 Hz, 1H), 5.65 (s, 1H), 5.90 (s, 1H), 5.94 (d, J=1.1 Hz, 2H), 6.62 (s, 1H), 6.80 (s, 1H), 7.42 (d, J=8.6 Hz, 2H), 7.99 ppm (d, J=8.6 Hz, 2H); 13 C NMR (100 MHz, CDCl3): \u03b4=21.0,",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "ppm; ESI-MS: m/z 468 [M+H] + ; HRMS: m/z [M+H] + calcd. for C25 H23ClNO6: 468.1208, found: 468.1200. General procedure for 34-41",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "H NMR (400 MHz, CDCl3): \u03b4=0.78 (t, J=7.4 Hz, 3H), 1.51 (dd, J=14.7, 7.3 Hz, 2H), 2.18 (td, J=7.3, 4.0 Hz, 2H), 2.54 (d, J=8.6 Hz, 1H), 2.87 (s, 2H), 3.18 (d, J=9.7 Hz, 1H), 3.28 (d, J=9.9 Hz, 1H), 3.47 (dd, J=8.8, 4.4 Hz, 1H), 3.61 (d, J=14.1 Hz, 1H), 4.18",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}